Treatment and composition for wound healing

Details for Australian Patent Application No. 2002302192 (hide)

Owner The University of Sydney

Inventors Sambrook, Philip Neil; Jackson, Christopher John

Agent Madderns

Pub. Number AU-B-2002302192

PCT Number PCT/AU02/00751

PCT Pub. Number WO2002/100445

Priority PR 5637 13.06.01 AU; PS 1433 02.04.02 AU

Filing date 11 June 2002

Wipo publication date 23 December 2002

Acceptance publication date 16 August 2007

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

A61K 38/43 (2006.01) Medicinal preparations containing peptides - Enzymes

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 19/04 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): PR 5637 13.06.01 AU; PS 1433 02.04.02 AU

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002302192

16 August 2007 Application Accepted

  Published as AU-B-2002302192

13 December 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002302193-Methods and pharmaceuticals for treating muscle insulin resistance and related conditions

2002302191-SOCS-5 MOLECULES, SCREENING THEREFORE AND THERAPEUTIC USES THEREOF